Product image

Razodex Capsules

Razodex Capsules – Advanced Relief for Erosive Esophagitis

Razodex is a potent gastrointestinal medication designed to provide long-lasting relief from severe acid-related symptoms in patients 12 years and older. It is primarily indicated for the healing of all grades of erosive esophagitis (EE) over an eight-week treatment course. Beyond initial healing, it is used for maintaining that healing and providing relief from heartburn for up to six months.

Razodex is also highly effective for the short-term (four-week) treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD). As an advanced proton pump inhibitor, it works by significantly reducing the amount of acid produced by the stomach. This reduction allows damaged esophageal tissue to recover and prevents the pain of recurrent acid reflux. The capsules provide stable acid control throughout the day and night with a convenient once-daily dose. It is a well-tolerated and essential therapy for individuals suffering from chronic or severe acid reflux disease.

  • Heals and maintains the healing of erosive esophagitis.
  • Provides long-term relief from heartburn and GERD symptoms.
  • Standard once-daily oral dosing.
  • Available as: Capsules 30MG and 60MG.

You may also like

Take it to your cart

Ezole Capsules
Ezole Capsules

Ezole Capsules – Targeted Suppression of Stomach Acid

Ezole Capsules contain Esomeprazole, a potent proton pump inhibitor de...

Risek Capsules
Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a...

EN-URA Tablets
EN-URA Tablets

EN-URA Tablets – Targeted Relief for Overactive Bladder

EN-URA is a specialized therapeutic option designed to manage bother...

Saltra Inhaler
Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used f...

Image NewsLetter
Icon primary
Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy